ENTA -8% on no news. Evidently, investors are literally interpreting Rick Gonzalez’s guidance for 2016 V-Pak sales of $2B—even though Gonzalez himself acknowledged on ABBV’s 4Q15 CC that $2B is a lowball figure ABBV is using to ensure a “beat” (after the embarrassment of missing the V-Pak end-2015-run-rate guidance).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.